Fetal Inflammation May Play Role in Preterm Labor

Share this content:
Fetal Inflammation May Play Role in Preterm Labor
Fetal Inflammation May Play Role in Preterm Labor

WEDNESDAY, April 25, 2018 (HealthDay News) -- Fetal inflammation and rejection of maternal antigens is associated with uterine contractility and aberrant fetal immune responses, which may play a role in preterm labor (PTL), according to a study published in the April 25 issue of Science Translational Medicine.

Noting that PTL may represent a breakdown in maternal-fetal tolerance, Michela Frascoli, Ph.D., from the University of California in San Francisco, and colleagues analyzed maternal and cord blood in patients with PTL and in healthy term controls.

The researchers found that cord blood from preterm infants had higher amounts of inflammatory cytokines and greater dendritic cell activation. Preterm cord blood was characterized by a population of central memory cells with a type 1 T helper phenotype, which was not seen in term infants, and by an increase in maternal microchimerism. Compared with term infants, T cells from preterm infants mounted a robust proliferative, proinflammatory response to maternal antigens, but did not respond to third-party antigens. T cells from preterm infants stimulated contractility of the uterine myometrium through interferon-γ and tumor necrosis factor-α. In mouse fetuses, adoptive transfer of activated T cells resulted in pregnancy loss.

"Our findings indicate that fetal inflammation and rejection of maternal antigens can contribute to the signaling cascade that promotes uterine contractility and that aberrant fetal immune responses should be considered in the pathogenesis of PTL," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »